These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2908336)

  • 21. Dependence studies of new compounds in the rhesus monkey, rat and mouse (1988).
    Aceto M; Bowman E; Harris L; May E
    NIDA Res Monogr; 1988; 90():468-515. PubMed ID: 2908337
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug dependence].
    Orekhov MN
    Med Sestra; 1989 May; 48(5):41-7. PubMed ID: 2788793
    [No Abstract]   [Full Text] [Related]  

  • 23. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotherapies for treatment of opioid dependence.
    Vocci FJ; Sorer H
    J Health Care Poor Underserved; 1992; 3(1):109-24; discussion 125-7. PubMed ID: 1356495
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment with tramadol can give rise to dependence and abuse].
    Näslund S; Dahlqvist R
    Lakartidningen; 2003 Feb; 100(9):712-4. PubMed ID: 12674559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translational medicine in ultra-long injectable opioid drug discovery--when abuse liability and toxicity meet analgesic efficacy.
    Sun WZ
    Acta Anaesthesiol Taiwan; 2006 Sep; 44(3):133-4. PubMed ID: 17036999
    [No Abstract]   [Full Text] [Related]  

  • 27. Progress report from the NIDA Addiction Research Center, Baltimore, Maryland.
    Jasinski DR; Boren JJ; Henningfield JE; Johnson RE; Lange WR; Lukas SE
    NIDA Res Monogr; 1984 Mar; 49():69-76. PubMed ID: 6148697
    [No Abstract]   [Full Text] [Related]  

  • 28. Dextropropoxyphene dependence: a cautionary note.
    Edwin T; Nammalvar N; Ramanujam V
    J Assoc Physicians India; 2001 May; 49():571-3. PubMed ID: 11361277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abuse potential and physical dependence liability studies with flupirtine maleate in laboratory animals.
    Sofia RD; Diamantis W; Gordon R
    Postgrad Med J; 1987; 63 Suppl 3():35-40. PubMed ID: 3447127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Some methodological problems in assessing dependence-producing properties of drugs in animals.
    Yanagita T
    Pharmacol Rev; 1975 Dec; 27(4):503-9. PubMed ID: 4823
    [No Abstract]   [Full Text] [Related]  

  • 31. Opioid tolerance and dependence: an inevitable consequence of chronic treatment?
    Adriaensen H; Vissers K; Noorduin H; Meert T
    Acta Anaesthesiol Belg; 2003; 54(1):37-47. PubMed ID: 12703345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid tolerance and dependence -- do they matter?
    Jage J
    Eur J Pain; 2005 Apr; 9(2):157-62. PubMed ID: 15737807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous opioid treatment for chronic noncancer pain: a time for moderation in prescribing.
    Colameco S; Coren JS; Ciervo CA
    Postgrad Med; 2009 Jul; 121(4):61-6. PubMed ID: 19641271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002.
    Gilson AM; Ryan KM; Joranson DE; Dahl JL
    J Pain Symptom Manage; 2004 Aug; 28(2):176-88. PubMed ID: 15276196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Office-based buprenorphine treatment for opioid-dependent patients.
    McCance-Katz EF
    Harv Rev Psychiatry; 2004; 12(6):321-38. PubMed ID: 15764468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescription Opioid Misuse Index: a brief questionnaire to assess misuse.
    Knisely JS; Wunsch MJ; Cropsey KL; Campbell ED
    J Subst Abuse Treat; 2008 Dec; 35(4):380-6. PubMed ID: 18657935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescription opioid dependence is associated with poorer outcomes in disabling spinal disorders.
    Dersh J; Mayer TG; Gatchel RJ; Polatin PB; Theodore BR; Mayer EA
    Spine (Phila Pa 1976); 2008 Sep; 33(20):2219-27. PubMed ID: 18725868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans.
    Eissenberg T; Greenwald MK; Johnson RE; Liebson IA; Bigelow GE; Stitzer ML
    J Pharmacol Exp Ther; 1996 Feb; 276(2):449-59. PubMed ID: 8632309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.